International Clinical Trial: A multicenter randomized controlled study on the efficacy of vonoprazan combined with high-dose amoxicillin dual therapy for first-line eradication of Helicobacter pylori in the Qinghai region

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600116011) titled 'A multicenter randomized controlled study on the efficacy of vonoprazan combined with high-dose amoxicillin dual therapy for first-line eradication of Helicobacter pylori in the Qinghai region' on Jan. 4.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Qinghai Provincial Xining Third People's Hospital

Condition: Helicobacter pylori infection

Intervention: 14-day quadruple therapy:Omeprazole 20 mg BID + Amoxicillin 1 g BID + Clarithromycin 500 mg BID + Bismuth agent 200 mg BID

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-04

Target Sample Siz...